Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Key Laboratory of Geriatrics, Fujian Provincial Center for Geriatrics, Fujian Medical University, Fuzhou, People's Republic of China.
Department of Cardiology, Fujian Provincial Hospital, Fujian Cardiovascular Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Clin Interv Aging. 2018 Apr 17;13:641-649. doi: 10.2147/CIA.S162764. eCollection 2018.
Inflammatory factors play a critical role in contrast-induced acute kidney injury (CI-AKI). Prealbumin, a nutritional and inflammatory indicator, is a well-established predictor of short- and long-term outcomes in numerous clinical conditions. The current study investigated the association of pre-procedural prealbumin levels with CI-AKI and long-term outcomes in geriatric patients after elective percutaneous coronary intervention (PCI).
A total of 558 patients aged≥75 years, who underwent elective PCI between January 2012 and December 2015, were selected for the current study. Pre-procedural prealbumin levels were measured before PCI. Multivariable logistic regression and Cox proportional hazard regression analyses were performed to identify the independent risk factors for CI-AKI and long-term mortality.
Out of 558 patients, 54 developed CI-AKI. The optimal cutoff value of prealbumin for detecting CI-AKI was 185.5 mg/L with 62.7% sensitivity and 70.4% specificity based on the receiver operating characteristic analysis (C-statistic=0.710; 95% confidence interval [CI] 0.673-0.751). Multivariable analysis demonstrated that prealbumin≤185.5 mg/L was significantly associated with CI-AKI (odds ratio [OR] 0.397; 95% CI 0.195-0.808; =0.011). Cox regression analysis demonstrated that prealbumin≤185.5 mg/L was associated with long-term mortality (adjusted hazard ratio [HR] 0.525; 95% CI 0.289-0.952; =0.034) during the follow-up.
Pre-procedural levels of prealbumin were independently associated with an increased risk of CI-AKI and long-term mortality in elderly patients undergoing elective PCI.
炎症因子在对比剂诱导的急性肾损伤(CI-AKI)中起着关键作用。前白蛋白是一种营养和炎症指标,在许多临床情况下,它是短期和长期预后的可靠预测指标。本研究旨在探讨择期经皮冠状动脉介入治疗(PCI)前白蛋白水平与老年患者 CI-AKI 及长期预后的关系。
本研究共纳入 2012 年 1 月至 2015 年 12 月期间行择期 PCI 的 558 例年龄≥75 岁的患者。在 PCI 前测量前白蛋白水平。采用多变量 logistic 回归和 Cox 比例风险回归分析确定 CI-AKI 和长期死亡率的独立危险因素。
558 例患者中,54 例发生 CI-AKI。基于受试者工作特征(ROC)分析,前白蛋白检测 CI-AKI 的最佳截断值为 185.5mg/L,灵敏度为 62.7%,特异度为 70.4%(C 统计值=0.710;95%置信区间[CI]:0.673-0.751)。多变量分析表明,前白蛋白≤185.5mg/L 与 CI-AKI 显著相关(比值比[OR]:0.397;95%CI:0.195-0.808;=0.011)。Cox 回归分析表明,前白蛋白≤185.5mg/L 与长期死亡率相关(调整后风险比[HR]:0.525;95%CI:0.289-0.952;=0.034)。
择期 PCI 前白蛋白水平与老年患者 CI-AKI 及长期死亡率的增加独立相关。